RxDoctor Payments Data

Jackson Kube, OD

Optometrist · Norfolk, NENPI 1255958070

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,910 of the $2,764 with a category attached, or 69.1%. 14 manufacturers reported payments, led by Coopervision Inc. at 53.1% of the total. Reporting peaked in 2024 at $1,454 and has fallen 74.3% since, to $374 in 2025. Among optometrist clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,764in general payments, 2019–2025

Across 79 payments — averaging $34.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$1K
  • Johnson & Johnson Vision Care, Inc.$239
  • AbbVie$208
  • Oyster Point Pharma, Inc.$180
  • Bausch & Lomb Americas Inc.$178
  • Sun Pharmaceutical Industries Inc.$141
  • plus $351 from 8 others

What the payments were for

  • Travel & lodging$85431%
  • Food & beverage$1,91069%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,764 in reported general payments places this provider in the 90th percentile of 383 optometrist providers in Nebraska.

See all optometrist providers in Nebraska

Medicare billing

Part B allowed, 2024
$42,561
Medicare patients
194
Services billed
653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate22$693
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha19$224
Latanoprost36$187

Paid to pharmacies, not to this prescriber.

Other optometrist in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →